symptom trajectories
Recently Published Documents


TOTAL DOCUMENTS

300
(FIVE YEARS 144)

H-INDEX

27
(FIVE YEARS 4)

Author(s):  
Lonneke M. A. Wijnhoven ◽  
José A. E. Custers ◽  
Linda Kwakkenbos ◽  
Judith B. Prins

Abstract Objective Breast cancer survivors (BCS) may experience problems to adjust to their situation after cancer treatment completion. In case of severe distress, an adjustment disorder (AD) might develop. This study investigates the course of AD symptoms during 1 year and its predictors in BCS up to 5 years post-treatment. Methods BCS completed the Hospital Anxiety and Depression Scale (HADS) at baseline, 3, 6, and 12 months. HADS total scores were defined as no mental disorder (MD) symptoms (≤ 10), AD symptoms (11–14), and any other MD symptoms (≥ 15). Over the course of four assessments, symptom trajectories were a priori defined as no MD symptoms, AD symptoms, fluctuating AD symptoms below and above cut-offs, or any other MD symptoms. Complementary, latent class growth analysis (LCGA) was used to identify data-driven trajectories. Results Among 293 BCS with complete data, the majority was classified as no MD symptoms (54.4%), followed by 37.5% in the fluctuating AD symptoms trajectory. Only 1.4% had AD symptoms, and 6.8% had any other MD symptoms. With LCGA (N = 459), three trajectories were found: stable no MD symptoms (58.6%), stable AD symptoms (32.9%), and high increasing any other MD symptoms (8.5%). Compared to BCS with no MD symptoms, BCS with fluctuating AD symptoms or any other MD symptoms were younger, less able to handle daily activities, and showed more social support discrepancy, neuroticism, and less optimism. Conclusions Results of our study showed that AD symptoms in BCS up to 5 years post-treatment fluctuate over 1 year. It is thus important to appropriately assess AD over the course of 5 years post-treatment as AD symptoms can fluctuate.


2022 ◽  
Vol 21 (1) ◽  
Author(s):  
Maxine H. Krengel ◽  
Clara G. Zundel ◽  
Timothy Heeren ◽  
Megan Yee ◽  
Avron Spiro ◽  
...  

Abstract Background Thirty years ago, Gulf War (GW) veterans returned home with numerous health symptoms that have been associated with neurotoxicant exposures experienced during deployment. The health effects from these exposures have been termed toxic wounds. Most GW exposure-outcome studies utilize group analyses and thus individual fluctuations in symptoms may have been masked. This study investigates health symptom trajectories in the same veterans over 25 years. Methods Veterans were categorized into 5 a priori trajectory groups for each health symptom and Chronic Multisymptom Illness (CMI) clinical case status. Multinomial logistic regression models were used to investigate associations between these trajectories and neurotoxicant exposures. Results Results indicate that more than 21 Pyridostigmine Bromide (PB) pill exposure was associated with consistent reporting of fatigue, pain, and cognitive/mood symptoms as well as the development of six additional symptoms over time. Chemical weapons exposure was associated with both consistent reporting and development of neurological symptoms over time. Reported exposure to tent heater exhaust was associated with later development of gastrointestinal and pulmonary symptoms. Veterans reporting exposure to more than 21 PB pills were more than 8 times as likely to consistently meet the criteria for CMI over time. Conclusion This study highlights the importance of the continued documentation of the health impacts experienced by GW veterans’, their resulting chronic health symptoms, and the importance of exposure-outcome relationships in these veterans now 30 years post-deployment.


2022 ◽  
pp. 108705472110680
Author(s):  
Hallie R. Brown ◽  
Holly B. Laws ◽  
Elizabeth A. Harvey

Objective: ADHD and ODD are commonly co-occurring, but often studied individually. This study evaluated common trajectories of these disorders and explored how they co-develop in early childhood. Method: Community parents ( N = 273) completed online surveys about their 2-year-old. Children’s inattention, hyperactivity/impulsivity, and oppositional defiant disorder symptoms over 2 years were examined using latent class, dual trajectory, and cross-lagged analyses. Results: Most children followed low symptom trajectories. A small portion showed high, moderate, or increasing trajectories. The hyperactive/impulsive domain of ADHD showed a declining symptoms group. Children in high ODD groups were likely to be in high ADHD symptom groups; the converse was true but probabilities were lower. Hyperactive/impulsive symptoms predicted ODD symptoms across time, more than vice versa. Conclusion: The study extends the small body of literature assessing early development of ADHD and ODD. Findings suggest that earlier intervention for symptoms of ADHD may mitigate risk of developing ODD.


2022 ◽  
Vol 226 (1) ◽  
pp. S584-S585
Author(s):  
Emma Allen ◽  
Melissa M. Goslawski ◽  
Allie Sakowicz ◽  
Mayan Alvarado-Goldberg ◽  
Emily S. Miller

Author(s):  
Ethan Otto ◽  
Eva Culakova ◽  
Sixu Meng ◽  
Zhihong Zhang ◽  
Huiwen Xu ◽  
...  

2022 ◽  
Vol 226 (1) ◽  
pp. S550
Author(s):  
Allie Sakowicz ◽  
Emma Allen ◽  
Mayan Alvarado-Goldberg ◽  
Maya Daiter ◽  
William A. Grobman ◽  
...  

2021 ◽  
Author(s):  
Omid V. Ebrahimi ◽  
Daniel J. Bauer ◽  
Asle Hoffart ◽  
Sverre Urnes Johnson

This 17-month longitudinal study on a representative sample of 4,361 Norwegian adults employs an observational ABAB design across six repeated assessments and three pandemic waves to systematically investigate the evolution of depressive symptomatology across all modifications of viral mitigation protocols (VMPs) from their onset to termination. Using Latent Change Score Models to analyze 26,166 observations, the study empirically corroborates that critical fluctuations in depressive symptomatology within and across individuals occur during the first three months of the pandemic, after which symptom trajectories are predominantly consolidated throughout the pandemic period. Contrary to established belief, female sex, young age, lower education and preexisting psychiatric diagnosis only served as adequate predictors of the initial shocks to symptomatology observed during the onset of the pandemic, and did not adequately predict subsequent change and the critical fluctuations observed in symptoms within and across individuals. Population-level trajectories demonstrated that symptom levels increased in accordance with the presence and strictness of VMPs. Upon predominant termination of VMPs, population-level symptoms began declining, while large heterogeneity was present across the adult population. Detrimental long-term adversities were revealed by 10% of the adults. These individuals displayed chaotic adaptation to the pandemic and its VMPs, exhibiting substantial increases in clinical levels of symptomatology ensuing partial re-opening of society and through the remainder of the pandemic, with these deleterious symptoms further projected to remain heightened ahead. Number of times exposed to quarantine was incrementally tied with increases in contemporaneously experienced and long-term depressive adversities, while information obtainment through unmonitored sources was associated with contemporaneous but not long-term states of heightened symptomatology.


2021 ◽  
Author(s):  
Benjamin W Nelson ◽  
Nicholas Peiper ◽  
Kirstin Aschbacher ◽  
Valerie Forman-Hoffman

Objective: Multimorbidity or the co-occurrence of multiple health conditions is increasing globally and associated with significant psychological complications. It is unclear whether digital mental health (DMH) interventions for patients experiencing medical multimorbidity (MMB) are effective, particularly given that this patient population faces more treatment resistance. Therefore, there is a need for initial preliminary research to examine whether DMH interventions are associated with reductions on depressive and anxiety symptoms in the context of MMB.Methods: This preregistered retrospective cohort intent-to-treat study with 2,819 patients enrolled in a therapist-supported DMH (TS-DMH) intervention examined the associations between MMB and mental health. Results: Results indicated that more MMB was significantly associated with greater presenting mental health symptom severity. MMB did not have a deleterious influence on depressive symptom trajectories across treatment, although having one medical condition was associated with a steeper decrease in anxiety symptoms compared to patients with no medical conditions. Finally, MMB was not associated with time to dropout, but was associated with higher dropout and was differentially associated with fewer beneficial treatment outcomes, although this is likely attributable to higher presenting symptom severity, rather than lesser symptom reductions during treatment. Conclusions: The MHP showed preliminary effectiveness as an evidence-based treatment for patients experiencing depression and anxiety in the context of MMB. Future DMH treatments and research might investigate tailored barrier reduction and extended treatment lengths for patients experiencing MMB to allow for greater treatment dose to reduce symptoms below clinical outcome thresholds.


2021 ◽  
Vol 12 ◽  
Author(s):  
Minhi Kang ◽  
Luisa Bohorquez-Montoya ◽  
Timothy McAuliffe ◽  
Stacy A. Claesges ◽  
Nutta-On Blair ◽  
...  

Background: Loneliness is one of the most distressing grief symptoms and is associated with adverse mental health in bereaved older adults. The endocannabinoid signaling (ECS) system is stress-responsive and circulating endocannabinoid (eCB) concentrations are elevated following bereavement. This study examined the association between loneliness and circulating eCB concentrations in grieving older adults and explored the role of eCBs on the association between baseline loneliness and grief symptom trajectories.Methods: A total of 64 adults [grief with high loneliness: n = 18; grief with low loneliness: n = 26; and healthy comparison (HC): n = 20] completed baseline clinical assessments for the UCLA loneliness scale. In grief participants, longitudinal clinical assessments, including the Inventory of Complicated Grief and 17-item Hamilton Depression Rating scales, were collected over 6 months. Baseline circulating eCB [N-arachidonoylethanolamine (AEA) and 2-arachidonoylglycerol (2-AG)] concentrations were quantified in the serum using isotope dilution, liquid chromatography-mass spectrometry; cortisol concentrations were measured in the same samples using radioimmunoassay.Results: Circulating AEA concentrations were higher in severely lonely grieving elders than in HC group; cortisol concentrations were not different among the groups. Cross-sectionally, loneliness scores were positively associated with AEA concentrations in grievers; this finding was not significant after accounting for depressive symptom severity. Grieving individuals who endorsed high loneliness and had higher 2-AG concentrations at baseline showed faster grief symptom resolution.Conclusions: These novel findings suggest that in lonely, bereaved elders, increased circulating eCBs, a reflection of an efficient ECS system, are associated with better adaptation to bereavement. Circulating eCBs as potential moderators and mediators of the loneliness-grief trajectory associations should be investigated.


Sign in / Sign up

Export Citation Format

Share Document